A cryptic transactivation domain of EZH2 binds AR and AR's splice variant promoting oncogene activation and tumorous transformation
L. Cai, G. Wang, J. Wang, J. Jin, K.-S. Park, X. Yu, W. Gong, H. S. Earp
This study identifies a cryptic transactivation domain of EZH2 that binds AR and AR-V7, promoting oncogene activation and tumorous transformation, and shows that targeting this interaction with a PROTAC reduces tumor growth.
bioRxiv · Aug 4, 2022Cancer Biology